The American Red Cross reported a 35% drop in blood donations as of Dec. 20-25. Officials continue to urge donors to be a hero by donating their blood for a cause.
A breast cancer drug paired with venetoclax significantly enhanced leukemia cell killing and durability in preclinical tests.
Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...
CAR T-cell therapy on the National Health Service offers adults with fast-moving B-cell leukemia years of life, fewer side ...
In addition to their work with the LLSC, First Onsite also completed a donation-matching campaign in support of Happy Days ...
In November, referring to her Leukemia diagnosis as 'terminal', the 34-year-old wrote, "During the latest clinical trial, my doctor told me that he could keep me alive for a year, maybe My first ...
Receiving a diagnosis of Chronic Myeloid Leukemia (CML) can be frightening, but it is important to understand that the management of this disease is one of the greatest success stories in modern ...
Hundreds of people gathered to take a freezing leap into the Gulf during the 10th annual Polar Plunge at the Salty Goat ...
A family in Tulare County is turning their grief into purpose by selling desserts at Cruda Fest to raise money for funeral ...
Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...
From Pacific islands to global fallout, a new report traces how decades of nuclear testing left a silent health crisis that ...
Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback